Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Apr;50(4):930–939. doi: 10.1172/JCI106565

Skin capillary blood flow in scleroderma

E Carwile LeRoy 1,2, John A Downey 1,2, Paul J Cannon 1,2
PMCID: PMC292008  PMID: 5547282

Abstract

Skin blood flow was measured by the clearance of radioactive xenon (133Xe) injected intracutaneously in eight patients with scleroderma and nine control subjects under conditions of controlled temperature and humidity. Scleroderma patients, on being cooled 1 hr at 18°C, had a rate constant of 133Xe clearance from the dorsal finger skin which was 0.04 ±0.07 min-1 (mean ±SD), compared with 0.23 ±0.15 min-1 in normal subjects (P < 0.005). The corresponding mean cutaneous blood flows were 2.9 ml/100 g per min in the scleroderma patients and 16.4 ml/100 g per min in normal subjects. After reflex warming by waterbath, clearance was similar in the two groups (0.33 ±0.1 vs. 0.40 ±0.09); these data suggest that diminished clearance in scleroderma patients on cooling resulted, at least in part, from functional or reversible interruption of the circulation. The skin temperatures of scleroderma patients after reflex warming remained lower than those of normal subjects, despite similar increases in sublingual temperatures. The dissociation of 133Xe clearance and skin temperature in scleroderma patients (i.e. subnormal skin temperatures with normal 133Xe clearance after reflex warming) suggests either abnormal thermal properties of scleroderma skin or selective vasoconstriction of the vessels which regulate heat exchange. The demonstrated interruption of the capillary circulation on cooling of the skin in patients with scleroderma may be important in the pathogenesis of this disorder. After oral pretreatment with guanethidine, five patients with scleroderma had increased 133Xe clearance and calculated blood flow on cooling, rising to normal in three of these patients. The potential of this technique for the quantitative sequential evaluation of skin blood flow in subjects with scleroderma and for the evaluation of empirical therapy is suggested.

Full text

PDF
930

Images in this article

935Image
on p.935
936Image
on p.936

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAITHWAITE F., FARMER F. T., HERBERT F. I. Observations on the vascular channels of tubed pedicles using radioactive sodium. III. Br J Plast Surg. 1951 Apr;4(1):38–47. doi: 10.1016/s0007-1226(51)80005-5. [DOI] [PubMed] [Google Scholar]
  2. Buchanan I. S., Humpston D. J. Nail-fold capillaries in connective-tissue disorders. Lancet. 1968 Apr 20;1(7547):845–847. doi: 10.1016/s0140-6736(68)90302-4. [DOI] [PubMed] [Google Scholar]
  3. Buchwald I., Davis P. J. Scleroderma with fatal heat stroke. JAMA. 1967 Jul 24;201(4):270–271. [PubMed] [Google Scholar]
  4. CONN H. L., Jr Equilibrium distribution of radioxenon in tissue: xenon-hemoglobin association curve. J Appl Physiol. 1961 Nov;16:1065–1070. doi: 10.1152/jappl.1961.16.6.1065. [DOI] [PubMed] [Google Scholar]
  5. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  6. Fleischmajer R., Krol S. Chemical synthesis of the dermis in scleroderma. Proc Soc Exp Biol Med. 1967 Oct;126(1):252–256. doi: 10.3181/00379727-126-32415. [DOI] [PubMed] [Google Scholar]
  7. HENSEL H. Messkopf zur Durchblutungs-registrierung an Oberflächen. Pflugers Arch. 1959;268(6):604–606. doi: 10.1007/BF00362296. [DOI] [PubMed] [Google Scholar]
  8. Harris E. D., Jr, Sjoerdsma A. Collagen profile in various clinical conditions. Lancet. 1966 Oct 1;2(7466):707–711. doi: 10.1016/s0140-6736(66)92976-x. [DOI] [PubMed] [Google Scholar]
  9. LASSEN N. A. MUSCLE BLOOD FLOW IN NORMAL MAN AND IN PATIENTS WITH INTERMITTENT CLAUDICATION EVALUATED BY SIMULTANEOUS XE-133 AND NA24 CLEARANCES. J Clin Invest. 1964 Sep;43:1805–1812. doi: 10.1172/JCI105054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Norton W. L., Hurd E. R., Lewis D. C., Ziff M. Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med. 1968 Jun;71(6):919–933. [PubMed] [Google Scholar]
  11. Sejrsen P. Blood flow in cutaneous tissue in man studied by washout of radioactive xenon. Circ Res. 1969 Aug;25(2):215–229. doi: 10.1161/01.res.25.2.215. [DOI] [PubMed] [Google Scholar]
  12. Sejrsen P. Epidermal diffusion barrier to 133Xe in man and studies of clearance of 133Xe by sweat. J Appl Physiol. 1968 Feb;24(2):211–216. doi: 10.1152/jappl.1968.24.2.211. [DOI] [PubMed] [Google Scholar]
  13. Varadi D. P., Lawrence A. M. Suppression of Raynaud's phenomenon by methyldopa. Arch Intern Med. 1969 Jul;124(1):13–18. [PubMed] [Google Scholar]
  14. WARNER G. F., DOBSON E. L., PACE N., JOHNSTON M. E., FINNEY C. R. Studies of human peripheral blood flow; the effect of injection volume on the intramuscular radiosodium clearance rate. Circulation. 1953 Nov;8(5):732–734. doi: 10.1161/01.cir.8.5.732. [DOI] [PubMed] [Google Scholar]
  15. Willerson J. T., Thompson R. H., Hookman P., Herdt J., Decker J. L. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. Ann Intern Med. 1970 Jan;72(1):17–27. doi: 10.7326/0003-4819-72-1-17. [DOI] [PubMed] [Google Scholar]
  16. Yeh S. Y., Peterson R. E. Solubility of krypton and xenon in blood, protein solutions, and tissue homogenates. J Appl Physiol. 1965 Sep;20(5):1041–1047. doi: 10.1152/jappl.1965.20.5.1041. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES